明基材 8215 - 股息配發率

現金殖利率: 1.19%、總殖利率: 1.19%、5年平均現金配發率: 58.86%
要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)

	EPS YoY		現金股利 YoY		現金配發率 YoY		全部配發率 YoY
2025 (5)	-1.14	0	0.30	-51.61	0.00	0	0.00	0
2024 (4)	0.62	-51.56	0.62	-48.33	100.00	6.67	100.00	6.67
2023 (3)	1.28	-67.76	1.20	-40.0	93.75	86.09	93.75	86.09

每股盈餘-近8季

	EPS QoQ YoY			本業EPS QoQ YoY			累計EPS QoQ YoY
26Q1 (8)	-0.64	37.25	-526.67	-0.79	21.78	-231.67	-0.64	43.86	-526.67
25Q4 (7)	-1.02	-264.29	-828.57	-1.01	-2425.0	-10200.0	-1.14	-850.0	-283.87
25Q3 (6)	-0.28	-2900.0	-300.0	-0.04	95.4	-106.25	-0.12	-175.0	-125.0
25Q2 (5)	0.01	-93.33	-95.65	-0.87	-245.0	-1342.86	0.16	6.67	-52.94
25Q1 (4)	0.15	7.14	0.0	0.60	5900.0	0.0	0.15	-75.81	0.0
24Q4 (3)	0.14	0.0	0.0	0.01	-98.44	0.0	0.62	29.17	0.0
24Q3 (2)	0.14	-39.13	0.0	0.64	814.29	0.0	0.48	41.18	0.0
24Q2 (1)	0.23	0.0	0.0	0.07	0.0	0.0	0.34	0.0	0.0

年/月	營收	月增率(%)	去年同期年增率(%)	累計營收	累計營收年增率(%)	近三月累計營收	存貨銷售比	備註(年增率變動50%需說明原因)
2026/6	16.39	0.46	13.04	94.92	5.46	49.46	N/A	-
2026/5	16.31	-2.6	15.96	78.53	4.0	49.12	N/A	-
2026/4	16.75	4.31	7.19	62.21	1.27	46.2	N/A	-
2026/3	16.06	19.92	-3.14	45.46	-0.74	45.46	0.87	-
2026/2	13.39	-16.39	-14.18	29.41	0.6	44.24	0.89	-
2026/1	16.02	7.95	17.55	16.02	17.55	44.68	0.88	-
2025/12	14.84	7.29	-7.77	178.46	-3.99	43.27	0.94	-
2025/11	13.83	-5.37	-17.57	163.62	-3.63	43.45	0.94	-
2025/10	14.61	-2.64	-10.49	149.8	-2.11	44.86	0.91	-
2025/9	15.01	-1.51	-4.73	135.18	-1.1	45.19	0.9	-
2025/8	15.24	2.01	-1.56	120.18	-0.63	44.68	0.91	-
2025/7	14.94	3.02	9.45	104.94	-0.5	43.51	0.94	-
2025/6	14.5	3.05	-15.98	90.0	-1.98	44.19	0.89	-
2025/5	14.07	-9.97	-1.5	75.5	1.25	46.27	0.85	-
2025/4	15.63	-5.73	8.9	61.43	1.91	47.81	0.82	-
2025/3	16.58	6.24	2.88	45.8	-0.27	45.8	0.81	-
2025/2	15.6	14.53	10.41	29.23	-1.98	45.36	0.81	-
2025/1	13.62	-15.57	-13.14	13.62	-13.14	46.54	0.79	-
2024/12	16.14	-3.8	32.81	185.94	8.56	49.24	0.7	-
2024/11	16.78	2.75	50.99	169.8	6.7	48.89	0.7	醫療相關營收成長及中國大陸政策拉動消費性電子產品需求。
2024/10	16.33	3.37	9.03	153.07	3.41	47.6	0.72	-
2024/9	15.79	2.01	-0.31	136.74	2.77	44.92	0.79	-
2024/8	15.48	13.43	4.1	120.95	3.19	46.39	0.76	-
2024/7	13.65	-20.91	-10.86	105.47	3.06	45.19	0.78	-
2024/6	17.26	20.82	7.77	91.82	5.51	45.89	0.66	-
2024/5	14.28	-0.45	-7.08	74.56	5.0	44.74	0.68	-
2024/4	14.35	-10.94	-4.11	60.28	8.34	44.59	0.68	-
2024/3	16.11	14.01	8.71	45.93	12.93	45.93	N/A	-
2024/2	14.13	-9.9	5.82	29.82	15.35	42.08	N/A	-
2024/1	15.69	27.93	25.54	15.69	25.54	39.06	N/A	-
2023/12	12.26	10.35	1.18	171.39	10.28	38.34	N/A	-
2023/11	11.11	-25.79	-10.43	159.13	11.05	41.92	N/A	-
2023/10	14.97	-5.48	28.41	148.02	13.08	45.68	N/A	-
2023/9	15.84	6.53	42.71	133.04	11.59	46.02	N/A	-
2023/8	14.87	-2.87	17.57	117.2	8.39	46.19	N/A	-
2023/7	15.31	-4.38	20.37	102.33	7.17	46.7	N/A	-
2023/6	16.01	4.16	18.11	87.02	5.15	46.35	N/A	-
2023/5	15.37	2.73	14.96	71.01	2.61	45.16	N/A	-
2023/4	14.96	0.96	5.47	55.63	-0.34	43.14	N/A	-
2023/3	14.82	10.98	5.85	40.67	-2.33	40.67	N/A	-
2023/2	13.35	6.87	4.47	25.85	-6.48	37.97	N/A	-
2023/1	12.49	3.11	-15.9	12.49	-15.9	37.02	N/A	-
2022/12	12.12	-2.31	-16.82	155.4	-5.71	36.18	N/A	-
2022/11	12.4	6.38	-5.53	143.29	-4.63	35.16	N/A	-
2022/10	11.66	5.03	-10.68	130.88	-4.54	35.41	N/A	-
2022/9	11.1	-12.23	-15.34	119.22	-3.89	36.47	N/A	-
2022/8	12.65	-0.55	-8.42	108.12	-2.54	38.92	N/A	-
2022/7	12.72	-6.18	-6.09	95.48	-1.71	39.65	N/A	-
2022/6	13.56	1.38	-6.13	82.76	-1.0	41.12	N/A	-
2022/5	13.37	-5.74	-8.96	69.2	0.07	41.56	N/A	-
2022/4	14.19	1.32	3.57	55.83	2.51	40.97	N/A	-
2022/3	14.0	9.53	0.5	41.64	2.15	41.64	N/A	-
2022/2	12.78	-13.96	-1.19	27.64	3.0	42.21	N/A	-
2022/1	14.86	1.97	6.92	14.86	6.92	42.56	N/A	-
2021/12	14.57	10.95	6.84	164.82	9.51	40.75	N/A	-
2021/11	13.13	0.58	-2.43	150.25	9.77	39.3	N/A	-
2021/10	13.05	-0.43	-3.32	137.12	11.11	39.98	N/A	-
2021/9	13.11	-5.06	1.02	124.06	12.88	40.47	N/A	-
2021/8	13.81	1.97	8.11	110.95	14.47	0.0	N/A	-
2021/7	13.54	-6.22	8.32	97.14	15.43	0.0	N/A	-